Evidence map›Paper›PMID 28493114›Full record

ReviewDer Urologe. Ausg. A2017

[Management of multiresistant bacteria in urology].

W Vahlensieck, R Rudolph, H-J Knopf, U Dahl, W Fabry

Abstract readReview
PubMed Publisher
In one paragraph

Review in Der Urologe. Ausg. A, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.3field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 3 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

W VahlensieckKurpark-Klinik, Kurstr. 41-45, 61231, Bad Nauheim, Deutschland. w.vahlensieck@kurpark-klinik.com.
R RudolphUrologische Gemeinschaftspraxis, Kirchheim, Deutschland.
H-J KnopfSt. Ansgar Krankenhaus, Höxter, Deutschland.
U Dahl, Frankfurt am Main, Deutschland.
W FabryLehrstuhl für Geriatrie, Universität Witten/Herdecke, Witten/Herdecke, Deutschland.
Praxis für Humangenetik · DEWitten/Herdecke University · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Contamination and infection with extensive drug resistant (XDR) bacteria are increasing in urology with the exception of methicillin resistant Staphylococcus aureus (MRSA) (stabilization). They often lead to logistic and therapeutical problems. Only 30-50% of XDR cases are of exogenous origin. To slow this trend, screening, hygiene programs, isolation, decontamination, targeted therapy of symptomatic infections, education programs, and success controls should be applied. Furthermore, all regulatory and legal instructions should be followed. Local hygiene networks help to find apt measures for XDR control. It is important to balance hygiene measures against hygiene hysteria. To prepare urological instruments, a local instrument preparation plan that takes into consideration all legal instructions should be followed. The efforts in health system general prophylactic measures should be supported. Only with consistent implementation in all areas of daily life (health care, local environment, animal husbandry, and soil contaminated within the framework of animal husbandry) can a substantial reduction of XDR bacteria be achieved in the long term.

Indexed as

HygieneMethicillin-Resistant Staphylococcus aureusAnti-Bacterial AgentsBacterial InfectionsCatheter-Related InfectionsCross InfectionDecontaminationEvidence-Based MedicineHumansRecurrenceSecondary PreventionUrinary Tract InfectionsAnti-Bacterial AgentsDecontaminationDrug resistance, bacterialHygiene networksProphylaxisScreening

Identifiers

PMID28493114
OpenAlexW3128907556

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.